Interview with Wendell Jones of Q² Solutions | EA Genomics
Q: What need is Q² Solutions | EA Genomics addressing?
A: As a leading provider of genomic services in clinical trials and discovery, Q² Solutions | EA Genomics advances science by harnessing technological expertise to drive understanding of the human genome and disease biology to detect the effects of therapies.
read moreInterview with Ben Solomon of GeneDx
Q: What need is GeneDx addressing?
A: GeneDx was started in 2000 by two NIH scientists with the mission of making genetic testing accessible for patients with rare diseases.
read moreInterview with Ty Ridenour of RTI International
Q: What need is RTI International addressing?
A: As an independent research institute, RTI is dedicated to improving the human condition. We answer questions that demand an objective and multidisciplinary approach—one that integrates expertise across the social and laboratory sciences, engineering, and international development.
read moreInterview with Madhuri Hegde, Vice President and Chief Science Officer of PerkinElmer’s Global Laboratory Services
Q: What need is Global Laboratory Services addressing?
A: PerkinElmer Genomics is global (genomics) laboratory service with laboratories in US, India and China, addressing genetic/genomic testing across the globe.
read moreInterview with Rita R. Colwell from University of Maryland College Park and John Hopkins School of Public Health
Q: What research are you or your lab focusing on and why, and what problem(s) are you trying to solve?
A: The research that I am focusing on is understanding the microbiome of the human system and the environment, which means understanding the gut flora and its relationship to health and disease.
read moreInterview with Dr. Nicholas Dracopoli of Personal Genome Diagnostics
Q: What need is Personal Genome Diagnostics (PGDx) addressing?
A: PGDx is developing standardized, clinical Next Generation Sequencing (NGS) kits to help enable effective treatment decisions for cancer patients.
read moreInterview with Mohsen Hejrati of Clusterone
Q: What need is Clusterone addressing?
A: AI and machine learning are becoming cornerstone technologies for scientists and engineers, but access to these technologies is still cumbersome.
read moreVC Investment in Precision Medicine Boomed in Q2 Mega-deals Hitting Record Levels
VC activity is booming in healthcare, with second quarter drawing in $5.1 billion in capital. That is 22% of the total $23 billion raised by all VC-based companies in the U.S., according to latest Pricewaterhouse Coopers quarterly report.
read moreInterview with Patrick Conway of Blue Cross and Blue Shield of North Carolina
Q: In the past, you served as director of the Center for Medicare and Medicaid Innovation. What are you most proud of accomplishing at CMMI?
A: During my tenure at the Centers for Medicare and Medicaid Services, one of my many roles included serving as the Director of the Center for Medicare and Medicaid Innovation.
read moreInterview with Cathleen Colon-Emeric of Duke University School of Medicine
Q: What research are you or your lab focusing on and why, and what problem(s) are you trying to solve?
A: We are focused on physical resilience, or the dynamic ability to maintain or recover function following a stressor.
read more
